Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

CME: 1.5

April 5, 2021
/ Print / Reprints /
| Share More
/ Text Size+

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer.

Post a comment to this article